OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
58 hedge funds and large institutions have $208M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+6
Holders Change %
+11.54%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
22
Reduced
13
Closed
4
Calls
$8K
Puts
$20K
Net Calls
-$12K
Net Calls Change
-$12K
Top Buyers
1 |
Invesco
Atlanta,
Georgia
|
+$3.42M |
2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.5M |
3 |
WP
Woodline Partners
San Francisco,
California
|
+$1.54M |
4 |
BlackRock
New York
|
+$1.23M |
5 |
![]()
Franklin Resources
San Mateo,
California
|
+$1.13M |
Top Sellers
1 |
ECM
ExodusPoint Capital Management
New York
|
-$1.34M |
2 |
JGC
J. Goldman & Co
New York
|
-$1.15M |
3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.02M |
4 |
OCA
Octagon Capital Advisors
New York
|
-$676K |
5 |
Walleye Capital
New York
|
-$325K |